title: Workshop report: Malaria vaccine development in Europe--preparing for the future.
abstract: The deployment of a safe and effective malaria vaccine will be an important tool for the control of malaria and the reduction in malaria deaths. With the launch of the 2030 Malaria Vaccine Technology Roadmap, the malaria community has updated the goals and priorities for the development of such a vaccine and is now paving the way for a second phase of malaria vaccine development. During a workshop in Brussels in November 2014, hosted by the European Vaccine Initiative, key players from the European, North American and African malaria vaccine community discussed European strategies for future malaria vaccine development in the global context. The recommendations of the European malaria community should guide researchers, policy makers and funders of global health research and development in fulfilling the ambitious goals set in the updated Malaria Vaccine Technology Roadmap.
authors.affiliation: European Vaccine Initiative, UniversitätsKlinikum Heidelberg, Im Neuenheimer Feld 326, 69120 Heidelberg, Germany. Electronic address: contact.us@euvaccine.eu.
authors.forename: Nicola K
authors.initials: NK
authors.lastname: Viebig
authors.affiliation: European Vaccine Initiative, UniversitätsKlinikum Heidelberg, Im Neuenheimer Feld 326, 69120 Heidelberg, Germany.
authors.forename: Flavia
authors.initials: F
authors.lastname: D'Alessio
authors.affiliation: The Jenner Institute, University of Oxford , Old Road Campus Research Building, Roosevelt Drive, Oxford, OX3 7DQ, UK.
authors.forename: Simon J
authors.initials: SJ
authors.lastname: Draper
authors.affiliation: Sanaria Inc., 9800 Medical Center Drive, Suite A209, Rockville, MD 20850, USA.
authors.forename: B Kim Lee
authors.initials: BK
authors.lastname: Sim
authors.affiliation: Institut für Tropenmedizin, Universitätsklinikum Tübingen, Wilhelmstraße 27, 72074 Tübingen, Germany; Centre de Recherches Médicales de Lambaréné, B.P. 118 Lambaréné, Gabon.
authors.forename: Benjamin
authors.initials: B
authors.lastname: Mordmüller
authors.affiliation: The National Institute for Biological Standards and Control (NIBSC), Blanche Lane, South Mimms, Potters Bar, Hertfordshire, EN6 3QG, UK.
authors.forename: Paul W
authors.initials: PW
authors.lastname: Bowyer
authors.affiliation: IRD MERIT UMR 216, 75006 Paris, France; COMUE Sorbonne Paris Cité, Université Paris Descartes, Faculté des Sciences Pharmaceutiques et Biologiques, 75270 Paris, France.
authors.forename: Adrian J F
authors.initials: AJ
authors.lastname: Luty
authors.affiliation: European Vaccine Initiative, UniversitätsKlinikum Heidelberg, Im Neuenheimer Feld 326, 69120 Heidelberg, Germany.
authors.forename: Stefan
authors.initials: S
authors.lastname: Jungbluth
authors.affiliation: Institut Pasteur, 25-28 Rue du Docteur Roux, 75015 Paris, France.
authors.forename: Chetan E
authors.initials: CE
authors.lastname: Chitnis
authors.affiliation: The Jenner Institute, University of Oxford , Old Road Campus Research Building, Roosevelt Drive, Oxford, OX3 7DQ, UK.
authors.forename: Adrian V S
authors.initials: AV
authors.lastname: Hill
authors.affiliation: Institut für Tropenmedizin, Universitätsklinikum Tübingen, Wilhelmstraße 27, 72074 Tübingen, Germany; Centre de Recherches Médicales de Lambaréné, B.P. 118 Lambaréné, Gabon.
authors.forename: Peter
authors.initials: P
authors.lastname: Kremsner
authors.affiliation: Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, L3 5QA, UK.
authors.forename: Alister G
authors.initials: AG
authors.lastname: Craig
authors.affiliation: Biomedical Primate Research Centre, Department of Parasitology, Lange Kleiweg 161, 2288 GJ Rijswijk, The Netherlands.
authors.forename: Clemens H M
authors.initials: CH
authors.lastname: Kocken
authors.affiliation: European Vaccine Initiative, UniversitätsKlinikum Heidelberg, Im Neuenheimer Feld 326, 69120 Heidelberg, Germany.
authors.forename: Odile
authors.initials: O
authors.lastname: Leroy
mesh_terms: D055808:Drug Discovery / Q000379:methods* / Q000639:trends; D004493:Education; D014943:Global Health; D006801:Humans; D017780:Malaria Vaccines / Q000276:immunology* / Q000302:isolation & purification*
chemical_list: D017780:Malaria Vaccines
keywords: Antigen discovery; Capacity building; Controlled human malaria infection; Correlates of protection; Malaria; Vaccine